Antabio announces achievement of milestone in the development of its metallo-carbapenemase inhibitor in collaboration with the Wellcome Trust

Antabio awarded EUR 742,000 (USD 1,02 million) funding from Bpifrance to support the discovery of New Gram-Negative Anti-Infective Agents

Antabio’s antibacterial programme receives € 4.7 Million Award from the Wellcome Trust

Argenta and Antabio Announce Drug Discovery Collaboration

Antabio and WiSEED announce the first successful round of crowdfunding applied to biotech start-up financing

Renowned leader in the anti-infective drug industry invests in Antabio

Antabio obtains financial support from Oséo

Antabio announces the completion of the first round of its 1 million euro seed financing

Antabio receives the financial support of BioMedicalAlliance

Creation of the company